Fig. 6

Verification of the prognostic significance of the USP2-differential genomic model with GSE66229, GSE26899 and GSE13861. (A-C) Kaplan-Meier curves of OS for high- and low- GC subpopulations. (D-F) Time-dependent ROC analysis of the USP2-differential genomic model showing the overall survival of patients with GC patients. Univariate (G-I) and multivariate (J-L) Cox regression models were used to determine the correlations between clinical characteristics and the USP2 differential riskscore.